177Lu-PSMA SPECT Quantitation at 6 Weeks (dose 2) Predicts Short Progression Free Survival for Patients Undergoing Lu PSMA I&T Therapy. - John, Nikeith; Pathmanandavel, Sarennya; Crumbaker, Megan; Counter, William; Bao Ho; Yam, Andrew O.; Wilson, Peter; Niman, Remy; Ayers, Maria; Poole, Aron; Hickey, Adam; Agrawal, Shikha; et al. (Journal of Nuclear Medicine, 2022)